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CONTEXT AND OBJECTIVE: Mammography is the best method for breast-cancer screening and is ca-
pable of reducing mortality rates. Studies that have assessed the clinical impact of mammography have 
been carried out using film mammography. Digital mammography has been proposed as a substitute for 
film mammography given the benefits inherent to digital technology. The aim of this study was to com-
pare the performance of digital and film mammography. 
DESIGN: Systematic review and meta-analysis. 
METHOD: The Medline, Scopus, Embase and Lilacs databases were searched looking for paired studies, 
cohorts and randomized controlled trials published up to 2009 that compared the performance of digital 
and film mammography, with regard to cancer detection, recall rates and tumor characteristics. The refer-
ence lists of included studies were checked for any relevant citations. 
RESULTS: A total of 11 studies involving 190,322 digital and 638,348 film mammography images were 
included. The cancer detection rates were significantly higher for digital mammography than for film 
mammography (risk relative, RR = 1.17; 95% confidence interval, CI = 1.06-1.29; I² = 19%). The advantage 
of digital mammography seemed greatest among patients between 50 and 60 years of age. There were 
no significant differences between the two methods regarding patient recall rates or the characteristics 
of the tumors detected.
CONCLUSION: The cancer detection rates using digital mammography are slightly higher than the rates 
using film mammography. There are no significant differences in recall rates between film and digital 
mammography. The characteristics of the tumors are similar in patients undergoing the two methods. 
reSUmO
CONTEXTO E OBJETIVO: A mamografia é o melhor método para rastreamento do câncer de mama, ca-
paz de reduzir a mortalidade. Os estudos que avaliam seu impacto clínico foram realizados com mamo-
grafia em filme. A mamografia digital é proposta para substituir a mamografia em filme com benefícios 
inerentes à tecnologia digital. O objetivo do estudo foi comparar o desempenho da mamografia digital 
com a mamografia em filme.  
TIPO DE ESTUDO: Revisão sistemática e metanálise. 
MÉTODO: Foram pesquisadas as bases Medline, Scopus, Embase e Lilacs, buscando-se por estudos parea-
dos, coortes e ensaios clínicos randomizados comparando a mamografia digital e a mamografia em filme, 
quanto à taxa de detecção de câncer, de reconvocação e características dos tumores, publicados até 2009. 
As referências dos estudos incluídos foram verificadas em busca de citações relevantes. 
RESULTADOS: Foi incluído um total de 11 estudos, somando 190.322 mamografias digitais e 638.348 em 
filme. A taxa de detecção do câncer pela mamografia digital foi significantemente maior (risco relativo, RR: 
1,17 [95% intervalo de confiança, IC = 1,06-1,29 I² = 19%]) do que pela mamografia em filme. A vantagem 
da mamografia digital parece maior em pacientes entre 50 e 60 anos. Não houve diferenças significantes 
nas taxas de reconvocação de pacientes e nas características dos tumores encontrados. 
CONCLUSÃO: A mamografia digital apresenta taxa de detecção de câncer pouco maior que a mamogra-
fia em filme. Não há diferenças significantes nas taxas de reconvocação entre a mamografia digital e a em 
filme. As características dos tumores são semelhantes em pacientes em ambos os métodos.
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INTRODUCTION
Breast cancer is the second most frequent malignant neoplasm 
among the female population.1 In Brazil, it has been estimated 
that there are 50.71 cases for every 100,000 women, second only 
to non-melanoma skin neoplasms. The specific mortality rate 
is 11.4 per 100,000 women, which means that, each year, more 
than 10,000 women die from this disease.2 There is evidence in 
the medical literature that suggests that periodic mammogra-
phy screening is the most effective method for early diagnosis 
of breast cancer, with significant reductions in the specific mor-
tality rates caused by this disease. The evidence indicates that 
this screening method is especially beneficial for women aged 
50 and over, although there are studies showing that this method 
also provides significant benefits for women between 40 and 49 
years of age.3-6 
One recent historic landmark in mammography was the 
United States Food and Drug Administration’s (FDA’s) approval 
of the first full-field digital equipment for breast-cancer screen-
ing, in January 2000.7 Initially, digital technology was merely 
used to orient mammography-guided intervention procedures, 
in which detectors allowed physicians to obtain images from a 
small field of view. Full-field digital mammography is intended to 
replace film mammography in screening and diagnosing breast 
cancer. Digital technology brings with it a series of implicit bene-
fits, which include storage of images in digital databases, without 
an ensuing loss of quality, and the ability to transmit images over 
long distances. One of the factors that most compromises film 
mammography is the fact that the images need to be developed 
and fixed chemically, and the image rejection rate due to pro-
cessing errors can surpass 20%.8 The need to repeat these exami-
nations increases costs and exposes patients to higher doses of 
ionizing radiation. Digital mammography does away with the 
chemical processing of images and, by enabling correction of 
brightness and contrast, can potentially reduce the rate of image 
rejection due to technical errors.
Other benefits inherent to digital technology are: the abil-
ity to amplify images on a monitor without the need to sub-
ject the patient to further X-ray exposure for magnified imag-
ing; the ability to subsequently manipulate image contrast and 
brightness, and to use filters (software that selects or excludes 
certain gray-scale tones); and the ability to make computer-
aided diagnoses using specific software that recognizes image 
patterns in lesions. However, all studies that demonstrate the 
effectiveness of mammography for reducing breast-cancer 
mortality have been based on traditional, film mammography.3 
A large proportion of the studies that assess digital mammog-
raphy have focused on technical data, like spatial resolution, 
contrast details and the calculable efficiency of the detector.9-11 
To date, none of the studies that have compared the perfor-
mance of digital mammography and film mammography have 
assessed the impact of digital mammography specifically in 
terms of mortality. This type of study may take many years or 
even decades. The studies that are currently available merely 
assess intermediate or substitute endpoints, like cancer detec-
tion rates, patient recall rates and the clinical characteristics of 
the tumors detected.12-14
OBJECTIVES
The objective of this systematic review of the scientific literature 
was to compare the performance of digital mammography and 
film mammography in terms of cancer detection rates, patient 
recall rates and characteristics of the tumors detected.
METHODS 
Type of study
Systematic review of the scientific literature and meta-analysis.
Types of studies included
Paired studies, cohort studies and clinical trials comparing film 
mammography and digital mammography that were published 
up to September 2009.
Types of participants
Women age 40 or over who were enrolled in breast cancer screen-
ing programs or who complained of specific ailments, and for 
whom mammography was recommended.
Types of endpoints
The following endpoints were assessed:
A. Cancer detection rate; 
B. Patient recall rate; 
C. Characteristics of the tumors detected.
The cancer detection rate is the ratio between the number of 
cancer cases confirmed through biopsy (histopathological anal-
ysis) and the number of cases detected by each method, in all 
patients screened. 
The recall rate is the proportion of the patients with images 
that are sufficiently suspect to require the patients to be called 
in again for further screening, additional propaedeutic investiga-
tion and possible biopsy (histopathological analysis).
In order to compare the characteristics of the tumors found, 
we evaluated the ratio of invasive tumors to in situ tumors found 
using each method. 
Subgroup analysis
The following subgroup analyses were conducted:
A. Cancer detection rate in patients 60 years old or younger;
B. Cancer detection rate in patients older than 60 years of age; 
C. Cancer detection rate in patients between 45 and 49 years old.
SyStematic review | Iared W, Shigueoka DC, Torloni MR, Velloni FG, Ajzen SA, Atallah ÁN, Valente O
252     Sao Paulo Med J. 2011; 129(4):250-60
Inclusion criteria
All studies that compared film and digital mammography in sim-
ilar populations in terms of the aforementioned endpoints were 
included in this study.
Exclusion criteria
Studies presenting any of the characteristics listed below were 
excluded:
A. Studies that assessed the detection rate for just one of the 
methods. 
B. Studies from which it was impossible to extract cancer detec-
tion data and recall data relating to one of the mammography 
methods. 
C. Studies in which cases of previously reported cancer(s) were 
included in the study sample. 
D. Studies that assessed merely one of the technical parameters. 
E. Studies that did not include an abstract in English, Portu-
guese or Spanish in the databases consulted. 
F. Studies that examined subpopulations of larger studies previ-
ously included in this review. 
Location
This meta-analysis was conducted at the Brazilian Cochrane 
Center at the Universidade Federal de São Paulo — Escola Pau-
lista de Medicina (Unifesp-EPM), within the Emergency Medi-
cine and Evidence-Based Medicine Program of the Department 
of Medicine.
Search strategy
The search strategy involved searching four electronic databases 
(Medline via PubMed, Embase, Lilacs and Scopus) for articles on 
the topics of digital and film mammography that had been pub-
lished up to September 2009. The bibliographic references of the 
studies included were checked in order to search for additional 
potentially relevant citations. The search strategy was sensitive 
to text and abstract wording, was unfiltered and used the follow-
ing strategies:
Databases: Medline via PubMed, Embase and Scopus
#1: MAMMOGRAPHY
#2: DIGITAL 
#3: #1 AND #2
Lilacs Database
#1: MAMMOGRAPHY
#2: MAMOGRAFÍA
#3: MAMOGRAFIA
#4: #1 OR #2 OR #3
#5: DIGITAL
#6: #4 AND #5
Study locations
Two reviewers (MRT and WI or FV and WI) independently 
assessed the titles and summaries of all the resulting citations 
identified in the electronic search. Studies that potentially met 
the inclusion criteria were then read in full. Divergent opinions 
were resolved by reaching a consensus. Studies for which no con-
sensus was reached were considered potentially eligible.
Data extraction
All studies with inclusion potential were separated for a full read-
ing, critical assessment and data extraction, and this was done 
independently by two reviewers (DCS and WI). 
A specific form was created for extracting the data from each 
study, and the following data were gathered: general information 
on each study (author and publication year), type of study, type of 
patients, study location, total number of cases, number of recall 
cases, total number of cases with a cancer diagnosis, positive pre-
dictive value and total numbers of in situ carcinomas and inva-
sive carcinomas. Where included, these same data were stratified 
according to age group.
The data extracted by each researcher were inserted into indi-
vidual spreadsheets that were subsequently compared. Divergent 
opinions were resolved by reaching a consensus.
Statistical analysis
We expressed the differences in cancer detection rates, patient 
recall rates and in situ and invasive cancer rates as relative risk 
(RR) rates using the statistical random-effects model for dichoto-
mous data.
Risk ratios and the respective 95% confidence intervals were 
calculated. The data were compared using forest plots.
Review Manager 5.0.20, which is a computer software freely 
distributed by the Cochrane Collaboration, was used for the cal-
culations and to generate the plots.
The heterogeneity of the estimated effects among the studies 
included was analyzed using the heterogeneity or inconsistency 
test (I²). I² values less than 30% were considered to be indicators 
of low heterogeneity; values between 30-50% were considered to 
be indicators of moderate heterogeneity; and values above 50% 
were considered to be indicators of high heterogeneity. 
RESULTS
A. Studies included
The electronic search identified 1,644 bibliographic citations: 1,203 
references in Medline, 214 in Embase, 198 in Scopus and 29 in 
Lilacs. After reading the titles and abstracts, and after eliminating 
duplicates, 26 articles were chosen for a full reading and critical 
assessment. Of these, 15 were excluded because they did not meet 
the inclusion criteria or because they met the exclusion criteria. 
Table 112,15-28 summarizes the reasons for excluding these 15 studies. 
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Figure 1. Flowchart for the process of study inclusion in the review.
Titles and abstracts
n = 1,644
Full text assessmet
n = 26
Data extraction
n = 11
1,618 studies excluded because they clearly
did not compare digital mammography 
with lm mammography
15 studies excluded for the reasons 
described in Table 1
Studies included
n = 11
Author Reason for exclusion
Cole et al.15 Assessment of cases with previously known cancer diagnoses
Hendrick et al.28 Retrospective study using data from Pisano’s 2005 Digital Mammographic Imaging Screening Trial (DMIST)14 study
Venta et al.17 Did not assess clinical data of interest for this systematic review
Lewin et al.18
Study conducted with part of the population of the complete study,30 which was published the following year and 
has been included in the systematic review
Nishikawa et al.19 Retrospective study using data from Pisano et al.14 DMIST study
Onishi et al.20 Study of population with prior surgical recommendation
Pisano et al.16 Retrospective study using data from Pisano et al.14 DMIST study
Ranganathan et al.21 Did not report data for calculating cancer detection rates and recall rates
Seo et al.22 Assessment using previously known mammary lesions
Skaane et al.23
Study that assessed endpoints other than those listed in the objective of this review, using data from the Skaane et 
al. 31 and Skaane et al.29 Oslo I12 and Oslo II13 studies
Skaane et al.12 First published paper from the study data included in the Skaane et al.31 Oslo I12 study
Skaane et al.24
Study that assessed endpoints other than the objective of this review, using data from the Skaane et al.31 and 
Skaane et al.29 Oslo I12 and Oslo II13 studies
Tosteson et al.25 Study that assessed endpoints other than those listed in the objective of this review (cost effectiveness)
Yamada et al.26 Study that assesses endpoints other than those listed in the objective of this review (technical parameters)
Yamada et al.27 Known cancer cases included
Table 1. Main reasons for excluding studies from the systematic review12,15-28
Upon completion of the search strategy and recovery, 11 
studies were ultimately included in the systematic review (Fig-
ure 1). 
Among the studies included, we found one randomized 
controlled trial (RCT),29 three paired studies (prospective stud-
ies in which all the patients included underwent both types of 
mammography)14,30,31 and seven cohort studies.32-38
The allocation concealment in the only RCT included was 
not clearly described in the published paper.29 
The cohort studies included a total of 130,199 digital mam-
mography images and 568,184 film mammography images. From 
the digital images, 801 cancers were detected; and from the film 
images, 3,341 cancers were detected.32-38
The RCT included 6,944 digital mammography images and 
16,985 film mammography images. From these, 41 and 64 cases 
of cancer were detected in the groups using digital and film mam-
mography respectively.29
The paired studies included a total of 53,179 digital mam-
mography images and film mammography images. Digital mam-
mography was able to detect 182 cases of cancer, while film mam-
mography was able to detect 194 cases.14,30,31
Table 214,23,29,30,32-38 summarizes the main characteristics of the 
studies included.
B. Effectiveness of digital mammography compared with 
film mammography for detecting breast cancer
The results showed homogeneity in terms of the cancer detection 
rate. The cancer detection rate was significantly higher among 
patients who underwent digital mammography.
Based on the combination of data from the 11 studies 
included in this systematic review, the average relative-risk esti-
mate for cancer detection among patients who underwent digi-
tal mammography was 1.17 (95% confidence interval, CI = 1.06-
1.29; I² = 19%), in relation to film mammography.
The combined RR, considering merely the seven cohort stud-
ies, was 1.21 (95% CI = 1.11-1.32; I² = 0%), and the RR for the 
RCT was 1.57 (95% CI = 1.06-2.32). 
On the other hand, taking into consideration only the paired 
studies, there was no significant difference in cancer detection 
rates between the two methods: average RR of 0.94 (95% CI = 
0.77-1.15; I² = 0%).
Figure 2 shows the forest plot with the same information.
C. Recall rate for digital mammography compared with film 
mammography 
There was great heterogeneity among the studies with regard to 
the patient recall rate (I² = 96%), even when they were analyzed 
according to study design (for cohort studies, I² = 95%; for paired 
studies, I² = 93%).
The meta-analysis did not identify any significant difference 
between the two methods with regard to the patient recall rate: RR 
= 1.07; 95% CI = 0.94-1.22; I² = 96%). However, the RCT revealed 
a significant difference, with higher recall rates among patients who 
underwent digital mammography (RR = 1.69; 95% CI = 1.46-1.96).
Figure 3 shows the same information in a forest plot.
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Study design Participants Comparison Endpoints assessed Study date
Study 
location
Del Turco et al.32
Cohort study, 
retrospective 
Women aged 50 to 69 in 
a breast cancer screening 
program
Digital versus film 
mammography
Cancer detection rate, 
patient recall rate and 
tumor characteristics. 
Assessment of subgroups 
by age group: 50-59 
years; 60-69 years
January 2004 
to October 
2005
Florence, Italy
Hambly et al.38
Cohort study, 
retrospective 
Women aged 50 to 64 years 
old invited to participate in a 
screening program
Digital versus film 
mammography
Digital versus film 
mammography
January 2005 
to December 
2007
Ireland
Heddson et al.33
Cohort study, 
retrospective 
Women in breast cancer 
screening program. 
Maximum age of 74 years, 
variable minimum age
Digital versus film 
mammography
Cancer diagnosis rate, 
patient recall rate and 
positive predictive value
January 2000 
to February 
2005 
Sweden
Lewin et al.30
Paired study, 
prospective
Women older than 40 years 
of age who came in for 
screening at either of the 
two centers. Symptomatic 
patients excluded.
Digital versus film 
mammography
Cancer detection rate 
and patient recall rate
2000 and 2001 
(estimated)
United States
Pisano et al.14
Paired study, 
prospective
49,528 patients who came 
in for screening at the 
participating institutions
Digital versus film 
mammography
Sensitivity, specificity, 
positive predictive value 
and negative predictive 
value of the screening 
methods
October 2001 
to November 
2003 
Thirty-three 
participating 
locations in 
United States 
and Canada
Sala et al.37
Cohort study, 
retrospective 
Women aged 50 to 69 years 
in a screening program
Digital versus film 
mammography
Cancer detection rate 
and patient recall rate
February 2002 
to January 
2007
Barcelona, 
Spain
Skaane et al.23
Paired study, 
prospective
Women aged 50 to 69 years 
in a screening program
Digital versus film 
mammography
Cancer detection rate 
and patient recall rate
January 2000 
to June 2000
Oslo, Norway
Skaane et al.29
Randomized trial, 
prospective
Women aged 45 to 69 years 
in a screening program
Digital versus film 
mammography
Recall rate, cancer 
detection rate, positive 
predictive value, 
sensitivity, specificity, 
tumor characteristics 
and discordant 
interpretations
November 
2000 to 
December 
2001
Oslo, Norway
Vernacchia et al.36
Cohort study, 
retrospective 
Women aged 40 years or 
older in a screening program
Digital versus film 
mammography
Cancer detection rate 
and patient recall rate
July 2004 to 
August 2008 
San Luis 
Obispo, 
California, 
United States
Vigeland et al.34
Cohort study, 
retrospective 
Women aged 50 to 69 years 
in a screening program
Digital versus film 
mammography
Cancer detection rate, 
patient recall rate and 
positive predictive value
February 2004 
to December 
2005
Vestfold, 
Norway
Vinnicombe et al.35
Cohort study, 
retrospective 
Women aged 50 years or 
older in a screening program
Digital versus film 
mammography
Cancer detection rate, 
patient recall rate and 
positive predictive value
January 2005 
to June 2007
London, 
United 
Kingdom
Table 2. Main characteristics of the studies included in the systematic review14,23,29,30,32-38
D. Characteristics of the tumors found using digital 
mammography, compared with film mammography
The characteristics of the tumors were seen to be similar from the 
two methods, in studies that provided this information. The rela-
tive risk of the proportion of invasive tumors in relation to the 
total number of tumors was 0.97 (95% CI = 0.91-1.04; I ² = 42%). 
Likewise, the relative risk of the proportion of in situ carcinomas 
was 1.14 (95% CI = 0.88-1.47, I ² = 48%). 
Figures 4 and 5 present the same information in the form of 
a forest plot graph.
e. Breast cancer detection rates in different age groups, 
comparing digital and film mammography
Subgroup analysis according to age group, in the cohort studies 
that included this information,32,35,38 revealed that digital mam-
mography was better than film mammography for detecting 
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Figure 2. Breast cancer detection rates from digital versus film mammography.
Digital mammography Film mammography
Weight
Risk Ratio Risk Ratio
Study or 
Subgroup
Events Total Events Total
M-H, Random, 
95% CI
M-H, Random,  
95% CI
1.1.1 Cohorts
Del Turco et al. 32 104 14,385 84 14,385 9.1% 1.24 [0.93, 1.65]
Hambly et al. 38 221 35,204 792 153,619 22.8% 1.22 [1.05, 1.41]
Heddson et al. 33 111 26,271 81 25,901 9.1% 1.35 [1.02, 1.80]
Sala et al. 37 25 6,074 54 12,958 3.8% 0.99 [0.62, 1.59]
Vernacchia et al. 36 142 21,548 20 4,838 3.8% 1.59 [1.00, 2.54]
Vigeland et al. 34 140 18,239 2105 324,763 19.4% 1.18 [1.00, 1.40]
Vinnicombe et al. 35 58 8,478 205 31,720 8.9% 1.06 [0.79, 1.42]
Subtotal (95% CI) 130,199 568,184 76.8% 1.21 [1.11, 1.32]
Total events 801 3341
Heterogeneity: Tau2 = 0.00; Chi2 = 3.53, df = 6 (P = 0.74); I2 = 0%
Test for overall effect: Z = 4.17 (P = 0.54)
1.1.2 Paired studies
Lewin et al. 30 25 6,736 33 6,736 3.2% 0.76 [0.45, 1.27]
Pisano et al. 14 138 42,760 136 42,760 12.3% 1.01 [0.80, 1.29]
Skaane et al. 31 19 3,683 25 3,683 2.4% 0.76 [0.42, 1.38]
Subtotal (95% CI) 53,179 53,179 17.9% 0.94 [0.77, 1.15]
Total events 182 194
Heterogeneity: Tau2 = 0.00; Chi2 = 1.56, df = 2 (P = 0.46); I2 = 0%
Test for overall effect: Z = 0.61 (P = 0.54)
1.1.3 Randomized clinical trials
Skaane et al. 29 41 6,944 64 16,985 5.3% 1.57 [1.06, 2.32]
Subtotal (95% CI) 6,944 16,985 5.3% 1.57 [1.06, 2.32]
Total events 41 64
Heterogeneity: Not applicable
Test for overall effect: Z = 2.25 (P = 0.02)
Total (95% CI) 190,322 638,348 100.0% 1.17 [1.06, 1.29]
Total events 1024 3599
Heterogeneity: Tau2 = 0.00; Chi2 = 12.30, df = 10 (P = 0.27); I2 = 19%
Test for overall effect: Z = 3.23 (P = 0.01) Favors film mammography
0.2 0.5 1 2 5
Favors digital mammography
tumors in patients between 50 and 60 years of age (RR = 1.23; 
95% CI = 1.05-1.44; I² = 0%). No significant differences were 
identified in groups older than 60 years of age (RR = 1.14; 95% CI 
= 0.95-1.38; I² = 0%) (Figure 6 and Figure 7).
The RCT assessed patients between the ages of 45 and 49 
years as well as patients older than 50 years. This trial found that 
digital mammography was more effective only in the older age 
group: RR = 1.58; 95% CI = 1.02 - 2.46; versus RR = 1.55; 95% CI 
= 0.67-3.58, respectively (Figure 8).
Moreover, despite the data available from the RCT did not 
allow its inclusion in the meta-analysis, Pisano, in the DMIST 
study14, reported that digital mammography showed greater 
accuracy for perimenopausal and premenopausal patients and in 
patients younger than 50 years with higher mammary density.
DISCUSSION
While mammography is a diagnostic test, studies that address the 
spectrum of patients of interest in clinical practice (women in 
breast cancer screening programs) are technically and ethically 
limited in terms of traditional methodology. The main limita-
tion is the lack of a reference standard (a “gold standard”) that 
is acceptable for negative tests. While a biopsy can be taken of 
the suspect lesion to confirm or reject the presence of cancer, if 
mammography images on the entire mass of both breasts come 
up negative, such patients cannot be subjected to histopathologi-
cal study. Thus, studies lack information on the number of false 
negative cases. Without this information, the sensitivity, speci-
ficity and negative predictive value cannot be reported. Even the 
positive tests confirmed by biopsy do not assess the contralat-
eral breast or other regions of the breast with the suspect lesion. 
Thus, without being able to create a 2 x 2 table, there are seri-
ous limitations with regard to obtaining data regarding sensitiv-
ity, specificity and negative predictive value. On the other hand, 
positive predictive values can be obtained. Nonetheless, the crite-
ria for determining that a test is positive or suspect are extremely 
variable and do not follow specific standards in different clinics, 
as seen by the extreme heterogeneity of recall rates found in the 
studies included in this meta-analysis.
The most appropriate means of assessing the effectiveness of 
mammography for screening for breast cancer is to interpret it 
like an intervention, such that the primary endpoint is the reduc-
tion in mortality rates. Since digital mammography is a relatively 
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Digital mammography Film mammography
Weight
Risk Ratio
Year
Risk Ratio
Study or 
Subgroup
Events Total Events Total
M-H, Random, 
95% CI
M-H, Random,  
95% CI
1..1 Cohorts
Heddson et al. 33 98 111 67 81 16.9% 1.07 [0.95, 1.20] 2007
Del Turco et al. 32 75 104 69 84 12.5% 0.88 [0.75, 1.03] 2007
Vigeland et al. 34 102 140 1,762 2,105 19.8% 0.87 [0.79, 0.96] 2008
Vinnicombe et al. 35 45 58 159 205 12.3% 1.00 [0.86, 1.17] 2009
Sala et al. 37 21 25 41 54 7.1% 1.11 [0.88, 1.39] 2009
Hambly et al. 38 175 211 646 792 25.2% 0.97 [0.90, 1.05] 2009
Subtotal (95% CI) 659 3,321 93.8% 0.97 [0.90, 1.04]
Total events 516 2744
Heterogeneity: Tau2 = 0.00; Chi2 = 9.85, df = 5 (P = 0.08); I2 = 49%
Test for overall effect: Z = 0.93 (P = 0.35)
1.4.2 Randomized clinical trials
Skaane et al. 29 30 41 44 64 6.2% 1.06 [0.83, 1.36] 2007
Subtotal (95% CI) 41 64 6.2% 1.06 [0.83, 1.36]
Total events 30 44
Heterogeneity: Not appicable
Test for overall effect: Z = 0.49 (P = 0.62)
Total (95% CI) 700 3,385 100% 0.97 [0.91, 1.04]
Total events 546 2,788
Heterogeneity: Tau2 = 0.00; Chi2 = 10.40, df = 6 (P = 0.11); I2 = 42%
Test for overall effect: Z = 0.84 (P = 0.40)
Test of subgroup differences: Not applicable Favors digital mammography
0.5 0.7 1 1.5 2
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Figure 4. Invasive carcinoma detection rates from digital versus film mammography
Digital mammography Film mammography
Weight
Risk Ratio Risk Ratio
Study or 
Subgroup
Events Total Events Total
M-H, Random, 
95% CI
M-H, Random,  
95% CI
1.2.1 Cohorts
Del Turco et al. 32 657 14,385 570 14,385 9.2% 1.15 [1.03, 1.29]
Hambly et al. 38 1406 35,204 4792 153,619 9.7% 1.30 [1.22, 1.38]
Heddson et al. 33 256 26,271 372 25,901 8.6% 0.70 [0.60, 0.82]
Sala et al. 37 257 6,074 718 12,958 8.9% 0.76 [0.66, 0.88]
Vernacchia et al. 36 1913 21,548 285 4,838 9.1% 1.51 [1.34, 1.70]
Vigeland et al. 34 746 18,239 13520 324,763 9.6% 0.98 [0.91, 1.06]
Vinnicombe et al. 35 406 8,478 1405 31,720 9.2% 1.08 [0.97, 1.20]
Subtotal (95% CI) 130,199 568,184 64.4% 1.04 [0.88, 1.23]
Total events 5650 21599
Heterogeneity: Tau2 = 0.03; Chi2 = 124.23, df = 6 (P = 0.00001); I2 = 95%
Test for overall effect: Z = 0.48 (P = 0.63)
1.2.2 Paired studies
Lewin et al. 30 793 6,736 1001 6,736 9.5% 0.79 [0.73, 0.86]
Pisano et al. 14 3592 42,760 3592 42,760 9.8% 1.00 [0.96, 1.05]
Skaane et al. 31 168 3,683 128 3,683 7.6% 1.31 [1.05, 1.64]
Subtotal (95% CI) 53,179 53,179 26.8% 0.99 [0.80, 1.22]
Total events 4553 4721
Heterogeneity: Tau2 = 0.03; Chi2 = 29.47, df = 2 (P = 0.00001); I2 = 93%
Test for overall effect: Z = 0.11 (P = 0.91)
1.2.3 Randomized clinical trials
Skaane et al. 29 294 6,944 425 16,985 8.8% 1.69 [1.46, 1.96]
Subtotal (95% CI) 6,944 16,985 8.8% 1.69 [1.46, 1.96]
Total events 294 425
Heterogeneity: Not applicable
Test for overall effect: Z = 7.06 (P < 0.00001)
Total (95% CI) 190,322 638,348 100.0% 1.07 [0.94, 1.22]
Total events 10479 26745
Heterogeneity: Tau2 = 0.05; Chi2 = 225.95, df = 10 (P < 0.00001); I2 = 96%
Test for overall effect: Z = 1.07 (P = 0.28)
Test for subgroup differences: Not applicable
Favors film mammography
0.70.5 1 1.5 2
Favors digital mammography
Figure 3. Patient recall rates from digital versus film mammography.
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Figure 5. In situ carcinoma detection rates from digital versus film mammography.
Digital mammography Film mammography
Weight
Risk Ratio Risk Ratio
Study or 
Subgroup
Events Total Events Total
M-H, Random, 
95% CI
M-H, Random,  
95% CI
1.3.1 Cohorts
Del Turco et al. 32 29 104 15 84 13.2% 1.56 [0.90, 2.71]
Hambly et al. 38 46 221 146 792 23.2% 1.13 [0.84, 1.52]
Heddson et al. 33 13 111 14 81 9.7% 0,68 [0.34, 1.36]
Sala et al. 37 4 25 13 54 5.4% 0.66 [0.24, 1.83]
Vigeland et al. 34 38 140 343 2,105 23.5% 1.67 [1.25, 2.22]
Vinnicombe et al. 35 13 58 46 205 13.5% 1.00 [0.58, 1.72]
Subtotal (95% CI) 659 3,321 88.6% 1.18 [0.89, 1.56]
Total events 143 577
Heterogeneity: Tau2 = 0.06; Chi2 = 10,09, df = 5 (P = 0.07); I2 = 50%
Test for overall effect: Z = 1.15 (P = 0.25)
1.3.2 Randomized clinical trials
Skaane et al. 29 11 41 20 64 11.4% 0.86 [0.46, 1.60]
Subtotal (95% CI) 41 64 11.4% 0.86 [0.46, 1.60]
Total events 11 20
Heterogeneity: Not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Total (95% CI) 700 3,385 100.0% 1.14 [0.08, 1.47]
Total events 154 597
Heterogeneity: Tau2 = 0.05; Chi2 = 11.46, df = 6 (P = 0.08); I2 = 48%
Test for overall effect: Z = 0.98 (P = 0.33)
Test for subgroup diferences: Not applicable
Favors film mammography
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Digital mammography Film mammography
Weight
Risk Ratio Risk Ratio
Study or 
Subgroup
Events Total Events Total
M-H, Random, 
95% CI
M-H, Random,  
95% CI
5.5.3 50 to 59 y.o.
Del Turco et al. 32 43 6,755 29 6,755 11.0% 1.48 [0.93, 2.37]
Hambly et al. 38 142 24,681 524 109,438 72.9% 1.20 [1.00, 1.45]
Subtotal (95% CI) 31,436 116,193 83.9% 1.24 [1.04, 1.47]
Total events 185 553
Heterogeneity: Chi2 = 0,67, df = 1 (P = 0.41); I2 = 0%
Test for overall effect: Z = 2.44 (P = 0.01)
5.5.5 50 to 60 y.o.
Vinnicombe et al. 35 32 5,263 98 18,939 16.1% 1.18 [0.79, 1.75]
Subtotal (95% CI) 5,263 18,939 16.1% 1.18 [0.79, 1.75]
Total events 32 98
Heterogeneity: Not applicable
Test for overall effect: Z = 0.79 (P = 0.43)
Total (95% CI) 36,699 135,132 100.0% 1.23 [1.05, 1.44]
Total events 217 651
Heterogeneity: Chi2 = 0.72, df = 2 (P = 0.70); I2 = 0%
Test for overall effect: Z = 2.55 (P = 0.01) Favors film mammography
0.20.1 100.5 1 2 5
Favors digital mammography
Figure 6. Breast cancer detection rates comparing digital mammography with film mammography in subgroups of patients between 50 
and 60 years old.
new method, it may take decades until there are sufficient data to 
compare this endpoint with findings from film mammography. 
The primary focus of the present systematic review was a surro-
gate outcome, i.e. the cancer detection rate.
Following the FDA’s approval of digital mammography in Jan-
uary 2000,7 several studies comparing this method and film mam-
mography were published. More recently, two systematic reviews 
on the matter were published. One, in 2007, included data from 
oral presentations given in congresses, in addition to published 
studies;39 and the other, in 2009, also included the results from 
a cohort study.35 Before the present review had been completed, 
other studies not included in earlier reviews were published, 
including a large cohort study with more than 188,000 women, 
of whom 35,000 had undergone digital mammography. Thus, 
updating the reviews is justified in the name of strengthening the 
degree of evidence available for subsequent decision-making.
It can be seen that, in older studies published up to 2005, 
there were no significant differences in cancer detection rate 
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Figure 7. Breast cancer detection rates comparing digital mammography with film mammography in subgroups of patients aged 60 or over.
Digital mammography Film mammography
Weight
Risk Ratio Risk Ratio
Study or 
Subgroup
Events Total Events Total
M-H, Fixed, 
95% CI
M-H, Fixed,  
95% CI
5.2.4 60 y.o. or more
Del Turco et al. 32 61 7,630 55 7,630 27.3% 1.11 [0.77, 1.59]
Hambly et al. 38 79 10,523 268 44,181 51.3% 1.24 [1.96, 1.59]
Subtotal (95% CI) 18,153 51,811 78.6% 1.19 [1.97, 1.47]
Total events 140 323
Heterogeneity: Chi2 = 0.24, df = 1 (P = 0.63); I2 = 0%
Test for overall effect: Z = 1.68 (P = 0.09)
5.2.6 over y.o.
Vinnicomble et al. 35 26 3,215 107 12,781 21.4% 0.97 [0.63, 1.48]
Subtotal (95% CI) 3,215 12,781 21.4% 0.97 [0.63, 1.48]
Total events 26 107
Heterogeneity: Not applicable
Test for overall effect: Z = 0.16 (P = 0.87)
Total (95% CI) 21,368 64,592 100.0% 1.14 [0.95, 1.38]
Total events 166 430
Heterogeneity: Chi2 = 1.01, df = 2 (P = 0.60); I2 = 0%
Test for overall effect: Z = 1.43 (P = 0.15)
0.2 0.5 1 2 5
Favors film mammography Favors digital mammography
Figure 8. Breast cancer detection rates comparing digital mammography with film mammography in subgroups of patients between 45 
and 49 years old and patients between 50 and 69 years old.
Digital mammography Film mammography
Weight
Risk Ratio Risk Ratio
Study or 
Subgroup
Events Total Events Total
M-H, Fixed, 
95% CI
M-H, Fixed,  
95% CI
5.1.1 RCT 45 to 49 y.o
Skaane  et al. 29 9 2,935 14 7,082 22.2% 1.55 [0.67, 3.58]
Subtotal (95% CI) 2,935 7,082 22.2% 1.55 [0.67, 3.58]
Total events 9 14
Heterogeneity: Not applicable
Test for overall effect: Z = 1.03 (P = 0.30)
5.1.2 RCT 50 to 69 y.o
Skaane et al. 29 32 4,009 50 9,903 77.8% 1.58 [1.02, 2.46]
Subtotal (95% CI) 4,009 9,903 77.8% 1.58 [1.02, 2.46]
Total events 32 50
Heterogeneity: Not applicable
Test for overall effect: Z = 2.03 (P = 0.04)
Total (95% CI) 6,944 16,985 100.0% 1.57 [1.06, 2.33]
Total events 41 64
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.97); I2 = 0%
Test for overall effect: Z = 2.28 (P = 0.02) Favors film mammography
0.2 0.5 1 2 5
Favors digital mammography
between the two types of mammography. However, the major-
ity of the studies published from 2007 onwards have reported a 
significantly higher detection rate from digital mammography, 
compared with film mammography. One hypothesis for explain-
ing this difference may relate to small technological advances in 
the equipment and to the learning curve for radiologists who use 
digital technology.
The subgroup assessment according to age groups showed 
that the superiority of digital mammography in terms of the can-
cer detection rate was more evident in the 50-60 year old group. 
This difference decreased and became insignificant in popula-
tions aged 60 years or over. The assessment of the population 
between 45 and 50 years of age in the RCT also did not demon-
strate any significant difference. One possible explanation for this 
is that mammary density is higher in populations of intermediate 
age than in women aged 60 or older, and that digital resources, 
like the use of filters and contrast manipulation, probably influ-
ence cancer detection. In women with greater lipid replacement 
in the mammary parenchyma, which is to be expected in older 
age groups, these image manipulation resources do not provide 
additional value. On the other hand, in younger populations, 
the density of the mammary parenchyma is probably too high 
for both types of mammography, thus leading to similar cancer 
detection rates.
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There was significant heterogeneity in the study results in 
terms of patient recall rates, which can be defined as the need 
for additional investigations to define the diagnosis of cancer. We 
believe that particular differences in the criteria used to recall 
patients, which were not standardized, were responsible for this 
difference in rates. 
With regard to the advantages associated with digital tech-
nology, the process of replacing film mammography with digital 
mammography is slow. This is partially explained by the still-high 
initial costs associated with digital equipment and partially by a 
lack of trust in the capacity of new technology to detect breast 
cancer with the same accuracy as the already-revered method of 
film mammography.
The DMIST study contained an estimate that the cost of dig-
ital mammography systems was 1.5 to 4 times the cost of film 
mammography systems.14 However, some authors believe that 
the replacement of film systems with digital systems is inevitable 
and that the path to its acceptance is one from which there is no 
turning back.40 Moreover, it is well-known that the natural ten-
dency is for the price of new technology to drop over time.
The results from this systematic review showed that there is a 
small difference in cancer detection rates in favor of digital mam-
mography. However, the most important finding was that there 
is no evidence to support any claim that digital mammography 
is inferior to film mammography in terms of cancer detection 
rates.
The possibility of long-distance transmission, which enables 
assessment by specialists located thousands of miles away from 
the examination center, is an important element of the digital 
system to consider in developing countries or in places with a 
reduced number of radiologists experienced in mammography. 
CONCLUSION
Digital mammography presents cancer detection rates that 
are slightly higher than the rates shown by film mammogra-
phy. There are no significant differences in patient recall rates 
between digital and film mammography. The characteristics of 
the tumors found are similar in patients who undergo digital and 
film mammography.
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